Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.
Medical robots are igniting interest of all the stakeholders in the healthcare industry physicians, health care professionals, providers, payers, technologists, planners and even the government.
For instance, citing the benefits offered by rehabilitation robots, Japan's Health Ministry has approved Cyberdyne's HAL exoskeleton suit as a medical device thus covering it under the public health insurance system. Similarly, in July 2015, ReWalk Robotics became the first company to secure commercial reimbursement in the U.S.
The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700.
To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.
Medical robots are igniting interest of all the stakeholders in the healthcare industry physicians, health care professionals, providers, payers, technologists, planners and even the government.
For instance, citing the benefits offered by rehabilitation robots, Japan's Health Ministry has approved Cyberdyne's HAL exoskeleton suit as a medical device thus covering it under the public health insurance system. Similarly, in July 2015, ReWalk Robotics became the first company to secure commercial reimbursement in the U.S.
The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700.
To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.
No comments:
Post a Comment